ENBREL (ETANERCEPT)

25 mg/0.5 mL (0.5 mL) subcutaneous syringe

• Inject 1 milliliter (50 mg) by subcutaneous route once weekly using 2Separate injection sites

50 mg/mL (1 mL) subcutaneous syringe

• Inject 1 milliliter (50 mg) by subcutaneous route once weekly

25 mg (1 mL) subcutaneous solution

• Inject 1 milliliter (25 mg) by subcutaneous route twice weekly 72-96 hours apart

Ankylosing spondylitis

• Inject 1 milliliter (25 mg) by subcutaneous route twice weekly 72-96 hours apart

• Inject 2 milliliters (50 mg) by subcutaneous route once weekly using 2 separate injection sites

• Inject 1 milliliter (50 mg) by subcutaneous route once weekly

• Inject 1 milliliter (50 mg) by subcutaneous route once weekly using 2Separate injection sites

• Inject 1 milliliter (50 mg) by subcutaneous route once weekly in the abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 2 milliliters (50 mg) by subcutaneous route once weekly in theabdomen, thigh, or outer area of upper arm (rotate sites)

Moderate to severe plaque psoriasis

• Inject 1 milliliter (25 mg) by subcutaneous route once weekly for 3 months in the abdomen, thigh, or outer area of upper arm; rotate sites

• Inject 0.5 milliliter (25 mg) by subcutaneous route once weekly for 3Months in the abdomen, thigh, or outer area of upper arm; rotate sites

• Inject 2 milliliters (50 mg) by subcutaneous route once weekly using 2 separate injection sites

• Inject 1 milliliter (50 mg) by subcutaneous route twice weekly

• Inject 1 milliliter (50 mg) by subcutaneous route once weekly using 2Separate injection sites

• Inject 1 milliliter (50 mg) by subcutaneous route once weekly in the abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 1 milliliter (50 mg) by subcutaneous route twice weekly for 3 months in the abdomen, thigh, or outer area of upper arm; rotate sites

• Inject 2 milliliters (50 mg) by subcutaneous route once weekly in theabdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 2 milliliters (50 mg) by subcutaneous route twice weekly for 3Months in the abdomen, thigh, or outer area of upper arm; rotate sites

Psoriatic arthritis

• Inject 1 milliliter (25 mg) by subcutaneous route twice weekly 72-96 hours apart

• Inject 2 milliliters (50 mg) by subcutaneous route once weekly using 2 separate injection sites

• Inject 1 milliliter (50 mg) by subcutaneous route once weekly

• Inject 1 milliliter (50 mg) by subcutaneous route once weekly using 2Separate injection sites

• Inject 1 milliliter (50 mg) by subcutaneous route once weekly in the abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 2 milliliters (50 mg) by subcutaneous route once weekly in theabdomen, thigh, or outer area of upper arm (rotate sites)

Rheumatoid arthritis

• Inject 1 milliliter (25 mg) by subcutaneous route twice weekly 72-96 hours apart

• Inject 2 milliliters (50 mg) by subcutaneous route once weekly using 2 separate injection sites

• Inject 1 milliliter (50 mg) by subcutaneous route once weekly

• Inject 1 milliliter (50 mg) by subcutaneous route once weekly using 2Separate injection sites

• Inject 1 milliliter (50 mg) by subcutaneous route once weekly in the abdomen, thigh, or outer area of upper arm (rotate sites)

• Inject 2 milliliters (50 mg) by subcutaneous route once weekly in theabdomen, thigh, or outer area of upper arm (rotate sites)